WHITE PLAINS, N.Y. -- Researchers at the White Plains Hospital Center for Cancer Care are currently evaluating patients with lung cancer for participation in nationally recognized clinical trials.
Patients with late-stage locally advanced or metastatic lung cancer may be eligible for recruitment into an ongoing multi-center clinical study known as CHECKMATE. The study is a Phase III clinical trial in patients with stage IV lung cancer who have not received prior chemotherapy or patients with recurrent squamous cell non-small cell lung cancer.
The purpose of the clinical trial is to evaluate different treatment regimens for improved overall survival and progression-free survival. CHECKMATE is being conducted nationwide. Of six study sites in New York State and the local region, White Plains Hospital is the only study site in Westchester County.
“In an age of increasingly personalized medicine, we now have the ability to find clinical trials of cancer medicines specific to a particular patient’s type and stage of cancer,” said Dr. Randy Stevens, Director of Radiation Oncology and Chair of the Institutional Review Board at White Plains Hospital.
The White Plains Hospital Center for Cancer Care has emerged as a prominent leader in advancing cancer treatment and clinical trials regionally, enabling patients in Westchester County to access research and pursue treatment closer to home without compromising expertise and quality.